Legis Daily

To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.

USA117th CongressHR-8299| House 
| Updated: 7/7/2022
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (7)
Tom O'Halleran (Democratic)Tony Cárdenas (Democratic)Angie Craig (Democratic)Ann M. Kuster (Democratic)John H. Rutherford (Republican)Joe Neguse (Democratic)Diana DeGette (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill allows changes to be made to medical devices without the need for supplemental applications or premarket notifications if the changes are made in accordance with a predetermined change control plan.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 13, 2022

Latest Companion Bill Action

S 117-4386
Introduced in Senate
Jul 7, 2022
Introduced in House
Jul 7, 2022
Referred to the House Committee on Energy and Commerce.
  • June 13, 2022

    Latest Companion Bill Action

    S 117-4386
    Introduced in Senate


  • July 7, 2022
    Introduced in House


  • July 7, 2022
    Referred to the House Committee on Energy and Commerce.

Health

Related Bills

  • S 117-4386: A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.

To allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.

USA117th CongressHR-8299| House 
| Updated: 7/7/2022
This bill allows changes to be made to medical devices without the need for supplemental applications or premarket notifications if the changes are made in accordance with a predetermined change control plan.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 13, 2022

Latest Companion Bill Action

S 117-4386
Introduced in Senate
Jul 7, 2022
Introduced in House
Jul 7, 2022
Referred to the House Committee on Energy and Commerce.
  • June 13, 2022

    Latest Companion Bill Action

    S 117-4386
    Introduced in Senate


  • July 7, 2022
    Introduced in House


  • July 7, 2022
    Referred to the House Committee on Energy and Commerce.
Gus M. Bilirakis

Gus M. Bilirakis

Republican Representative

Florida

Cosponsors (7)
Tom O'Halleran (Democratic)Tony Cárdenas (Democratic)Angie Craig (Democratic)Ann M. Kuster (Democratic)John H. Rutherford (Republican)Joe Neguse (Democratic)Diana DeGette (Democratic)

Energy and Commerce Committee

Health

Related Bills

  • S 117-4386: A bill to allow for devices with a predetermined change control plan to be marketed without submitting a supplemental application or premarket notification if the changes to such devices are consistent with such plan.
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted